当前位置: 首页 > 公司动态News
iPRECIO网络研讨会
发布时间:2021-05-26

iPRECIO将于6月16日(周三)举行美国, 中国, 欧洲 市场网络研讨会。



希望您能参与。



主要发言人为https://insidescientific.com/profile/christian-schnell/注册页面在5月的第一周上线。



AmHealthMedSupply


https://bit.ly/3dVKG4Q






Innovative drug infusion technology for laboratory animals.

JapaneseEnglish
SMP-310RSMP-200

News

  • EventHave you ever wanted to get more out of your in-vivo pharmaceutical studies? Have a burning question about programmable pumps and implication of refinement and reduction of animal use? Join Dr. Christian Schnell in his upcoming webinar on Programmable pumps for compounds delivery in oncology research: implication for refinement and reduction of animal use. More information and registration < here >

    May 17, 2021


  • NewsiPRECIO Programmable Minipumps for continuous delivery lenalidomide (LLD) in chronic lymphocytic leukemia (CLL). Video, https://youtu.be/d8CHR7et5zs from Start to 7 minutes: Rodent Studies of PK, Safety and Tolerability of LLD in Healthy and SCID Mice by Dr Jamie Oliver Chief Medical Officer of Starton Therapeutics (https://startontx.com/). IMS/SMP-300 for mice or larger used. Photo of SMP-200 for rats of larger shown.

    February 24, 2021


  • NewsNew review article on iPRECIO® - Linkedin Article – “Programmable pumps offer precise and translatable delivery of compounds to stress-free animals”
    https://www.linkedin.com/pulse/programmable-pumps-offer-precise-translatable-delivery-tsung-tan/?trackingId=i9CxNGMbQJye6JF6HVLJSw%3D%3D

    February 9, 2021


  • NewsUS20200330445A1: Continuous delivery of lenalidomide and other immunomodulatory agents
    "After the tumor reached an average size of 100-150 mm, iPrecio pump was surgically implanted into each of the mice . Dosing began twenty - four hours post pump implantation. Each of Groups 3-6 was treated lenalidomide via continuous subcutaneous infusion at different hourly rate. The dosing lasted 14 days followed by one day off the treatment and lasted for another 14 days . The iPrecio pump was replaced after 14 days." For full reference: - Click -

    December 1, 2020


  • NewsIMS-200 version 13 Revision 532renew has been released
    An important Application Software update has been released. Please contact us for downloading and installation instructions. Please share with us UCD-200 Serial Number. It can be found on the back of the programming device which plugs into the USB port of your PC. The upgrade is free and compatible with windows 10. Contact us <click here>

    September 18, 2020


DMP-100

Our Mission with
iPRECIO® Product Portfolio:


Make it as easy as possible to evaluate efficacy of molecules/agents in different animal models and species.

Make the results as relevant as possible to the clinic. (Exposure profile, quantitative pharmacology, untethered free moving (stress free, group housing (socialization), ..…)


The use of iPRECIO® pumps will have a positive impact on experimental conditions and the relevance of results achieved. Initial costs maybe higher but in the long run the use of the pump could be cost saving in the context of the whole compound development.

Page top

LIVE WEBINAR // Programmable Pumps for Compound Delivery in Oncology Research

 

Date: Wednesday, June 16, 2021

Time: 11:00 am ET | 5:00 pm CET

 

 

 

In oncology drug discovery programs, modulating target engagement via drug-delivery technologies can enable pivotal pharmacological studies. Over the past decade, there is increasing interest in establishing a robust mechanistic understanding of the pharmacokinetics–pharmacodynamics (PK–PD) relationship of a given compound and its connection to the anti-tumor efficacy profile.

 

In this webinar, Christian Schnell will describe the validation studies performed in his pharmacology unit with iPRECIO pumps implanted in rats and mice. Accurate PK-PD assessment and corresponding antitumor activity were assessed among several drug discovery programs. Christian will provide evidence that the investigation of such compound specific relationships are a pre-requisite for the planning of meaningful efficacy studies in preclinical models and the subsequent translation into patient’s clinical trials.

 

Key topics include:

 

·     Drug delivery with implantable infusion pumps

 

·     Chronic dosing regimens for quantitative pharmacology

 

·     Complementary use of implantable pumps with radio telemetry

 

 

To register, click the button above or go to: bit.ly/3eDyapJ

 

 

 

 

 

 

 

#ShareScience #LifeScienceWebinar #InsideScientific

下一篇:没有了